anthralin has been researched along with interleukin-8 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobozy, A; Farkas, B; Kemény, L; Kenderessy, AS; Michel, G; Olasz, E; Ruzicka, T | 1 |
| Jessat, H; Mrowietz, U; Schwarz, A; Schwarz, T | 1 |
| Chignell, CF; Hayden, PJ; Lange, RW; Luster, MI | 1 |
| Bata-Csörgö, Z; Dobozy, A; Farkas, A; Kemény, L; Kiss, M; Koreck, A; Pivarcsi, A; Széll, M; Szöny, BJ | 1 |
| Feng, H; Gao, JW; Li, XY; Tang, MY; Xu, LF; Zheng, JR | 1 |
| Brück, J; Carevic, M; Eberle, FC; Fehrenbacher, B; Ghoreschi, K; Holstein, J; Müller-Hermelink, E; Schäfer, I; Schaller, M; Schittek, B | 1 |
6 other study(ies) available for anthralin and interleukin-8
| Article | Year |
|---|---|
The interleukin-8 receptor: a potential target for antipsoriatic therapy?
Topics: Anthralin; Calcitriol; Cells, Cultured; Cyclosporine; Flow Cytometry; HLA-DR Antigens; Humans; Interleukin-8; Keratinocytes; Neutrophils; Psoriasis; Receptors, Interleukin; Receptors, Interleukin-8A; Recombinant Proteins | 1994 |
Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-alpha, but not IL-1.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Biological Assay; Cell Culture Techniques; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Monocytes; Tumor Necrosis Factor-alpha | 1997 |
Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species.
Topics: Acetylcysteine; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antibodies; Antioxidants; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Interleukin-8; Keratinocytes; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Thiourea; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha; Vitamin E | 1998 |
Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT.
Topics: Actins; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cell Line; Cell Line, Transformed; Cells, Cultured; Gene Expression Regulation; Humans; Immunohistochemistry; Interleukin-10; Interleukin-8; Keratinocytes; Receptors, Interleukin; Receptors, Interleukin-10; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Inhibition of the nuclear factor-kappaB signaling pathway by leflunomide or triptolide also inhibits the anthralin-induced inflammatory response but does not affect keratinocyte growth inhibition.
Topics: Anthralin; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cell Proliferation; Cells, Cultured; Diterpenes; Enzyme Inhibitors; Epoxy Compounds; Humans; I-kappa B Proteins; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-8; Isoxazoles; Keratinocytes; Leflunomide; NF-kappa B; Phenanthrenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetrazolium Salts; Thiazoles | 2005 |
Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Topics: Administration, Cutaneous; Anthralin; Apoptosis; beta-Defensins; Biopsy; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dermatologic Agents; Fluorescent Antibody Technique; Humans; Interleukin-17; Interleukin-22; Interleukin-6; Interleukin-8; Interleukins; Keratin-10; Keratin-16; Keratin-5; Keratinocytes; Ki-67 Antigen; Psoriasis; Skin; Tissue Culture Techniques | 2017 |